| Literature DB >> 12617742 |
Bélaid Bouhemad1, Jack Richecoeur, Qin Lu, Luiz M Malbouisson, Philippe Cluzel, Jean-Jacques Rouby.
Abstract
BACKGROUND: Intravenous injection of contrast material is routinely performed in order to differentiate nonaerated lung parenchyma from pleural effusion in critically ill patients undergoing thoracic computed tomography (CT). The aim of the present study was to evaluate the effects of contrast material on CT measurement of lung volumes in 14 patients with acute lung injury.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12617742 PMCID: PMC154113 DOI: 10.1186/cc1852
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Figure 1Changes in computed tomography (CT) attenuation with increasing concentrations of contrast material in the solution. HU, Hounsfield units.
Clinical and respiratory characteristics of the 14 patients with acute lung injury
| Patient no | Age/sex | Cause of ALI | Lung morphology* | Outcome | SAPS II | LISS | PaO2:FiO2 (mmHg) |
| Group 1 | |||||||
| 1 | 67/M | BPN | D | 42 | 1.7 | 176 | |
| 2 | 34/M | PC | PA | S | 55 | 3.5 | 262 |
| 3 | 81/M | BPN | LA | D | 44 | 1.7 | 292 |
| 4 | 54/M | BPN | PA | S | 16 | 2.0 | 205 |
| 5 | 68/M | BPN | LA | S | 27 | 1.7 | 132 |
| 6 | 67/M | BPN | LA | S | 46 | 1.5 | 238 |
| 7 | 74/M | BPN | LA | D | 64 | 1.66 | 164 |
| Mean ± SD | 64 ± 15 | 42 ± 16 | 2.0 ± 0.7 | 210 ± 57 | |||
| Group 2 | |||||||
| 8 | 72/M | BPN | LA | S | 79 | 1.5 | 250 |
| 9 | 49/M | PC | PA | S | 22 | 2.3 | 250 |
| 10 | 22/M | BPN | LA | S | 24 | 2 | 136 |
| 11 | 48/M | BPN | LA | D | 49 | 2 | 139 |
| 12 | 41/M | BPN | LA | S | 29 | 1.66 | 182 |
| 13 | 35/M | BPN | PA | D | 74 | 2.75 | 150 |
| 14 | 69/M | BPN | LA | D | 27 | 2.33 | 160 |
| Mean ± SD | 42 ± 18 | 43 ± 24 | 2.1 ± 0.4 | 181 ± 49 |
In group 1 computed tomgraphy (CT) sections were acquired before and 30 s after injection of contrast material, and in group 2 the CT sections were obtained before and 15 min after injection of contrast material. *The morphological CT pattern is classified into lobar (LA) and patchy (PA) CT attenuations, according to the definitions reported by Puybasset and coworkers [4]. BPN, ventilator associated bronchopneumonia; D, died; F, female; FiO2, fractional inspired oxygen; LISS, Lung Injury Severity Score; M, male; PaO2, arterial oxygen tension; S, survived; SAPS II, Simplified Acute Physiological Score.
Pulmonary arterial computed tomography attenuations before and after injection of contrast material in the two groups of patients
| Patient no | Mean CT attenuation before injection (HU) | Mean CT attenuation after injection (HU) | Pulmonary concentration of contrast material (%) |
| Group 1 (30 s after injection) | |||
| 1 | 31 | 245 | 1.9 |
| 2 | 45 | 218 | 1.8 |
| 3 | 49 | 110 | 0.3 |
| 4 | 49 | 169 | 1.2 |
| 5 | 36 | 265 | 2 |
| 6 | 43 | 146 | 0.7 |
| 7 | 46 | 219 | 1.4 |
| Mean ± SD | 43 ± 7 | 196 ± 56 | 1.3 ± 0.8 |
| Group 2 (15 min after injection) | |||
| 8 | 43 | 83 | 0.005 |
| 9 | 62 | 67 | 0 |
| 10 | 25 | 60 | 0 |
| 11 | 21 | 60 | 0 |
| 12 | 39 | 55 | 0 |
| 13 | 65 | 75 | 0 |
| 14 | 30 | 72 | 0.07 |
| Mean ± SD | 41 ± 17 | 67 ± 10 | 0.02 ± 0.002 |
CT, computed tomography; HU, Hounsfield units.
Figure 2Three representative mediastinal (upper panels) and parenchymal (lower panels) windows of computed tomography (CT) sections obtained before (baseline), and 30 s and 15 min after injection of contrast material in one patient. At 30 s, both lung parenchyma and pulmonary vessels are opacified. At 15 min, contrast material can be observed only in the lung parenchyma. The black line delineates lung parenchyma (accentuated contrast after injection of contrast material) from pleural effusion (same contrast after injection of contrast material).
Apparent lung volumes before and after injection of contrast material in the two groups of patients
| Patients | Before injection | After injection | |
| Group 1 (30 s after injection) | |||
| Total volume (ml) | 2546 ± 914 | 2542 ± 909 | NS |
| Volume of gas (ml) | 1444 ± 849 | 1358 ± 794 | 0.03 |
| Volume of tissue (ml) | 1105 ± 235 | 1193 ± 245 | 0.02 |
| Group 2 (15 min after injection) | |||
| Total volume (ml) | 2801 ± 882 | 2826 ± 833 | NS |
| Volume of gas (ml) | 1415 ± 853 | 1337 ± 838 | 0.02 |
| Volume of tissue (ml) | 1386 ± 109 | 1488 ± 157 | 0.01 |
The two-way analysis of variance for one within factor (before and after injection of contrast material) and one grouping factor (group 1 and group 2) showed an absence of interaction between the two groups.
Figure 3Individual percentage of changes in the apparent volume of lung tissue 30 s and 15 min after injection of 80 ml contrast material in patients in group 1 (upper panel) and group 2 (lower panel). The horizontal line indicates the mean value of the apparent volume of lung tissue. Blacks bars represent individual percentage of maximum artifactual increase in lung tissue calculated according to the hypothesis that the 80 ml of contrast material penetrated into the alveolar–interstitial space and formed an interface with the alveolar gas.
Figure 4Correlation (left panels) and agreement (right panels) between volumes of aliquots (Valiq) calculated using Lungview® and measured from lung weight after instillation of lung water (upper panels) and a solution containing 5% of contrast material (lower panels) into the human lung phantom. In the left panels, the dotted line represents the identity line and the solid line represents the linear regression line. In the right panels, the solid line represents the difference between calculated (using Lungview®) and measured (actual) aliquots (bias), and the dotted lines represents 2 SD (precision of the bias, according to the Bland–Altman method).
Individual increases in lung tissue volumes following injection of contrast material in the two groups of patients
| Patient no | Apparent increase in lung tissue (ml) | Maximum artifactual increase in lung tissue (ml) | Minimum actual increase in lung tissue (ml) |
| Group 1 (30 s after injection) | |||
| 1 | 27 | 0 | 27 |
| 2 | 31 | 21 | 10 |
| 3 | 38 | 2 | 36 |
| 4 | 74 | 43 | 31 |
| 5 | 139 | 70 | 69 |
| 6 | 96 | 14 | 82 |
| 7 | 173 | 146 | 27 |
| Mean ± SD | 83 ± 57 | 42 ± 52 | 40 ± 26 |
| Group 2 (15 min after injection) | |||
| 8 | 24 | 37 | 0 |
| 9 | 32 | 26 | 6 |
| 10 | 77 | 57 | 19 |
| 11 | 108 | 9 | 99 |
| 12 | 107 | 11 | 96 |
| 13 | 100 | 26 | 74 |
| 14 | 266 | 48 | 218 |
| Mean ± SD | 102 ± 80 | 31 ± 18 | 73 ± 76 |